REGENERON PHARMACEUTICALS, INC. Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for June 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 30 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 616.67 | 31 | 19,117 | 23,973 | 24 K to 24 K (-0.13 %) |
Jun 30 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 614.64 | 69 | 42,410 | 24,004 | 24.1 K to 24 K (-0.29 %) |
Jun 30 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 612.67 | 153 | 93,739 | 24,073 | 24.2 K to 24.1 K (-0.63 %) |
Jun 30 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 611.44 | 50 | 30,572 | 24,226 | 24.3 K to 24.2 K (-0.21 %) |
Jun 30 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 610.73 | 58 | 35,422 | 24,276 | 24.3 K to 24.3 K (-0.24 %) |
Jun 30 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 609.46 | 39 | 23,769 | 24,334 | 24.4 K to 24.3 K (-0.16 %) |
Jun 29 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 609.37 | 1,500 | 914,055 | 6,200 | 7.7 K to 6.2 K (-19.48 %) |
Jun 29 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 609.68 | 100 | 60,968 | 1,400 | 1.5 K to 1.4 K (-6.67 %) |
Jun 29 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 608.29 | 500 | 304,145 | 1,500 | 2 K to 1.5 K (-25.00 %) |
Jun 29 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 607.54 | 200 | 121,508 | 2,000 | 2.2 K to 2 K (-9.09 %) |
Jun 29 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 606.80 | 200 | 121,360 | 2,200 | 2.4 K to 2.2 K (-8.33 %) |
Jun 29 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 609.37 | 500 | 304,685 | 1,650 | 2.2 K to 1.7 K (-23.26 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 555.67 | 8,900 | 4,945,463 | 20,000 | |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 635.24 | 46 | 29,221 | 24,373 | 24.4 K to 24.4 K (-0.19 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 634.63 | 89 | 56,482 | 24,419 | 24.5 K to 24.4 K (-0.36 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 633.56 | 82 | 51,952 | 24,508 | 24.6 K to 24.5 K (-0.33 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 631.25 | 78 | 49,238 | 24,590 | 24.7 K to 24.6 K (-0.32 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 630.84 | 82 | 51,729 | 24,668 | 24.8 K to 24.7 K (-0.33 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 628.64 | 39 | 24,517 | 24,750 | 24.8 K to 24.8 K (-0.16 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 626.56 | 56 | 35,087 | 24,789 | 24.8 K to 24.8 K (-0.23 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 624.65 | 40 | 24,986 | 24,845 | 24.9 K to 24.8 K (-0.16 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 626.19 | 8,388 | 5,252,482 | 24,885 | 33.3 K to 24.9 K (-25.21 %) |
Jun 24 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 555.67 | 8,900 | 4,945,463 | 33,273 | 24.4 K to 33.3 K (+36.52 %) |
Jun 22 2020 | REGN | REGENERON PHARMACE ... | Bassler Bonnie L | Director | Option Exercise | M | 391.92 | 2,559 | 1,002,923 | 10,235 | |
Jun 22 2020 | REGN | REGENERON PHARMACE ... | Bassler Bonnie L | Director | Sell | S | 631.37 | 11 | 6,945 | 643 | 654 to 643 (-1.68 %) |
Jun 22 2020 | REGN | REGENERON PHARMACE ... | Bassler Bonnie L | Director | Sell | S | 630.01 | 2,548 | 1,605,265 | 654 | 3.2 K to 654 (-79.58 %) |
Jun 22 2020 | REGN | REGENERON PHARMACE ... | Bassler Bonnie L | Director | Buy | M | 391.92 | 2,559 | 1,002,923 | 3,202 | 643 to 3.2 K (+397.98 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 52.03 | 7,226 | 375,969 | 0 | |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 30.63 | 2,180 | 66,773 | 0 | |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 596.36 | 294 | 175,330 | 15,277 | 15.6 K to 15.3 K (-1.89 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 595.50 | 403 | 239,987 | 15,571 | 16 K to 15.6 K (-2.52 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 594.35 | 747 | 443,979 | 15,974 | 16.7 K to 16 K (-4.47 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 593.25 | 109 | 64,664 | 16,721 | 16.8 K to 16.7 K (-0.65 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 592.20 | 214 | 126,731 | 16,830 | 17 K to 16.8 K (-1.26 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 591.61 | 233 | 137,845 | 17,044 | 17.3 K to 17 K (-1.35 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 590.70 | 153 | 90,377 | 17,277 | 17.4 K to 17.3 K (-0.88 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 588.80 | 147 | 86,554 | 17,430 | 17.6 K to 17.4 K (-0.84 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 587.55 | 373 | 219,156 | 17,577 | 18 K to 17.6 K (-2.08 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 586.54 | 413 | 242,241 | 17,950 | 18.4 K to 18 K (-2.25 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 585.76 | 130 | 76,149 | 18,363 | 18.5 K to 18.4 K (-0.70 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 584.62 | 99 | 57,877 | 18,493 | 18.6 K to 18.5 K (-0.53 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 583.06 | 111 | 64,720 | 18,592 | 18.7 K to 18.6 K (-0.59 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 582.69 | 18 | 10,488 | 18,703 | 18.7 K to 18.7 K (-0.10 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 581.40 | 112 | 65,117 | 18,721 | 18.8 K to 18.7 K (-0.59 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 30.63 | 2,180 | 66,773 | 18,833 | 16.7 K to 18.8 K (+13.09 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Payment of Exercise | F | 587.90 | 3,670 | 2,157,593 | 16,653 | 20.3 K to 16.7 K (-18.06 %) |
Jun 17 2020 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 52.03 | 7,226 | 375,969 | 20,323 | 13.1 K to 20.3 K (+55.17 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Option Exercise | M | 391.92 | 1,706 | 668,616 | 6,823 | |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Option Exercise | M | 391.92 | 1,706 | 668,616 | 8,529 | |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 625.00 | 1,706 | 1,066,250 | 643 | 2.3 K to 643 (-72.63 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Buy | M | 391.92 | 1,706 | 668,616 | 2,349 | 643 to 2.3 K (+265.32 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 616.19 | 99 | 61,003 | 643 | 742 to 643 (-13.34 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 615.28 | 80 | 49,222 | 742 | 822 to 742 (-9.73 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 613.03 | 5 | 3,065 | 822 | 827 to 822 (-0.60 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 612.52 | 265 | 162,318 | 827 | 1.1 K to 827 (-24.27 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 611.46 | 164 | 100,279 | 1,092 | 1.3 K to 1.1 K (-13.06 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 610.41 | 202 | 123,303 | 1,256 | 1.5 K to 1.3 K (-13.85 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 609.48 | 161 | 98,126 | 1,458 | 1.6 K to 1.5 K (-9.94 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 608.62 | 330 | 200,845 | 1,619 | 1.9 K to 1.6 K (-16.93 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 607.64 | 251 | 152,518 | 1,949 | 2.2 K to 1.9 K (-11.41 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Sell | S | 606.64 | 149 | 90,389 | 2,200 | 2.3 K to 2.2 K (-6.34 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Zoghbi Huda Y | Director | Buy | M | 391.92 | 1,706 | 668,616 | 2,349 | 643 to 2.3 K (+265.32 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 3,500 | 954,450 | 0 | |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 624.56 | 59 | 36,849 | 24,373 | 24.4 K to 24.4 K (-0.24 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 621.56 | 16 | 9,945 | 24,432 | 24.4 K to 24.4 K (-0.07 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 620.70 | 58 | 36,001 | 24,448 | 24.5 K to 24.4 K (-0.24 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 619.73 | 66 | 40,902 | 24,506 | 24.6 K to 24.5 K (-0.27 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 616.00 | 31 | 19,096 | 24,572 | 24.6 K to 24.6 K (-0.13 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 614.41 | 34 | 20,890 | 24,603 | 24.6 K to 24.6 K (-0.14 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 613.53 | 23 | 14,111 | 24,637 | 24.7 K to 24.6 K (-0.09 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 612.74 | 177 | 108,455 | 24,660 | 24.8 K to 24.7 K (-0.71 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 611.82 | 14 | 8,565 | 24,837 | 24.9 K to 24.8 K (-0.06 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 608.91 | 65 | 39,579 | 24,851 | 24.9 K to 24.9 K (-0.26 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 607.50 | 445 | 270,338 | 24,916 | 25.4 K to 24.9 K (-1.75 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 610.18 | 2,512 | 1,532,772 | 25,361 | 27.9 K to 25.4 K (-9.01 %) |
Jun 12 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 3,500 | 954,450 | 27,873 | 24.4 K to 27.9 K (+14.36 %) |
Jun 11 2020 | REGN | REGENERON PHARMACE ... | Sanofi | Sell | S | 597.48 | 120,234 | 71,837,410 | 279,766 | 400 K to 279.8 K (-30.06 %) | |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 1,500 | 409,050 | 3,500 | |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 2,250 | 613,575 | 5,000 | |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 2,250 | 613,575 | 7,250 | |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 2,500 | 681,750 | 9,500 | |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 3,500 | 954,450 | 12,000 | |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | M | 272.70 | 3,500 | 954,450 | 15,500 | |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 610.25 | 527 | 321,602 | 24,373 | 24.9 K to 24.4 K (-2.12 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 609.53 | 681 | 415,090 | 24,900 | 25.6 K to 24.9 K (-2.66 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 608.50 | 1,511 | 919,444 | 25,581 | 27.1 K to 25.6 K (-5.58 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 607.47 | 619 | 376,024 | 27,092 | 27.7 K to 27.1 K (-2.23 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 606.79 | 353 | 214,197 | 27,711 | 28.1 K to 27.7 K (-1.26 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 605.14 | 289 | 174,885 | 28,064 | 28.4 K to 28.1 K (-1.02 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 604.14 | 50 | 30,207 | 28,353 | 28.4 K to 28.4 K (-0.18 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 603.68 | 131 | 79,082 | 28,403 | 28.5 K to 28.4 K (-0.46 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Sell | S | 602.38 | 110 | 66,262 | 28,534 | 28.6 K to 28.5 K (-0.38 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 1,086 | 643,379 | 28,644 | 29.7 K to 28.6 K (-3.65 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 1,500 | 409,050 | 29,730 | 28.2 K to 29.7 K (+5.31 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 1,630 | 965,661 | 28,230 | 29.9 K to 28.2 K (-5.46 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 2,250 | 613,575 | 29,860 | 27.6 K to 29.9 K (+8.15 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 1,630 | 965,661 | 27,610 | 29.2 K to 27.6 K (-5.57 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 2,250 | 613,575 | 29,240 | 27 K to 29.2 K (+8.34 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.40 | 1,811 | 1,072,836 | 26,990 | 28.8 K to 27 K (-6.29 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 2,500 | 681,750 | 28,801 | 26.3 K to 28.8 K (+9.51 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 2,536 | 1,502,402 | 26,301 | 28.8 K to 26.3 K (-8.79 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 3,500 | 954,450 | 28,837 | 25.3 K to 28.8 K (+13.81 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Payment of Exercise | F | 592.43 | 2,536 | 1,502,402 | 25,337 | 27.9 K to 25.3 K (-9.10 %) |
Jun 10 2020 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Buy | M | 272.70 | 3,500 | 954,450 | 27,873 | 24.4 K to 27.9 K (+14.36 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 607.20 | 2 | 1,214 | 28,743 | 28.7 K to 28.7 K (-0.01 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 606.50 | 15 | 9,098 | 28,745 | 28.8 K to 28.7 K (-0.05 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 605.40 | 9 | 5,449 | 28,760 | 28.8 K to 28.8 K (-0.03 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 604.51 | 21 | 12,695 | 28,769 | 28.8 K to 28.8 K (-0.07 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 603.64 | 11 | 6,640 | 28,790 | 28.8 K to 28.8 K (-0.04 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 602.48 | 10 | 6,025 | 28,801 | 28.8 K to 28.8 K (-0.03 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 601.56 | 10 | 6,016 | 28,811 | 28.8 K to 28.8 K (-0.03 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 600.53 | 2 | 1,201 | 28,821 | 28.8 K to 28.8 K (-0.01 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 599.59 | 15 | 8,994 | 28,823 | 28.8 K to 28.8 K (-0.05 %) |
Jun 02 2020 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Sell | S | 598.58 | 5 | 2,993 | 28,838 | 28.8 K to 28.8 K (-0.02 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 595.00 | 500 | 297,500 | 7,700 | 8.2 K to 7.7 K (-6.10 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 578.00 | 500 | 289,000 | 8,200 | 8.7 K to 8.2 K (-5.75 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 598.02 | 500 | 299,010 | 2,400 | 2.9 K to 2.4 K (-17.24 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 500 | 290,000 | 2,900 | 3.4 K to 2.9 K (-14.71 %) |
Jun 01 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 578.94 | 1,000 | 578,940 | 6,643 | 7.6 K to 6.6 K (-13.08 %) |